Finance

Lists
T1EV34:BVMF
Teva Pharmaceutical Industries Bdr
R$ ९८.१०
०.००%
(०.००) 1D
अक्टोबर ७, १३:३५:०३ GMT-३  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for T1EV34...
Mkt. cap
४७.१२ अरब
Avg. vol.
१२७.००
Volume
०.००
52-wk high
R$ १०१.९०
52-wk low
R$ ५१.६०
Shares outstanding
१.१७ अरब
No. of employees
३२ हजार
Mkt. cap
४७.१२ अरब
Avg. vol.
१२७.००
Volume
०.००
52-wk high
R$ १०१.९०
52-wk low
R$ ५१.६०
Shares outstanding
१.१७ अरब
No. of employees
३२ हजार
News stories
From web sources and news partners
Investor's Business Daily
Investor's Business Daily
·
५ घण्टा पहिले
Teva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind Approval
Investing.com
Investing.com
·
९ घण्टा पहिले
Oppenheimer raises Teva stock price target on Weltruza approval
Profile
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
About Teva Pharmaceutical Industries Bdr
CEORichard Francis
Employees३२ हजार
Founded१९४४ फेब्रुअरी १३
Headquarters-
Sector-
Websiteteva.co.il
Last report
२०२६ जुलाई २९
Fiscal period
Q2 2026
US$ ०.०२ / US$ ०.११
-८१.४६%miss
Revenue / Est. (USD)
४.१४ अरब / ४.०३ अरब
+२.७९%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
४.४८ अरब
४.७१ अरब
३.९८ अरब
४.१४ अरब
Cost of goods sold
२.१८ अरब
२.०६ अरब
२.०१ अरब
१.९९ अरब
Cost of revenue
२.१८ अरब
२.०६ अरब
२.०१ अरब
१.९९ अरब
Research and development expenses
२५.६० करोड
२६.७० करोड
२२.२० करोड
९७.०० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
९७.३० करोड
१.१२ अरब
१.०० अरब
१.०३ अरब
Operating expense
१.२४ अरब
१.३७ अरब
१.२१ अरब
१.९९ अरब
Total operating expenses
३.४१ अरब
३.४३ अरब
३.२२ अरब
३.९८ अरब
Operating income
१.०७ अरब
१.२८ अरब
७६.३० करोड
१६.७० करोड
Other non operating income
-२.७० करोड
-
-१.३० करोड
-६.९० करोड
EBT including unusual items
६४.८० करोड
९.०० करोड
४३.६० करोड
-४५.५० करोड
EBT excluding unusual items
८३.२० करोड
१.०८ अरब
५४.७० करोड
-५.७० करोड
Income tax expense
२१.४० करोड
-३९.०० करोड
६.७० करोड
१२.१० करोड
Effective tax rate
३३.०२%
-४३३.३३%
१५.३७%
-२६.५९%
Other operating expenses
९०.०० लाख
-१.७० करोड
-१.४० करोड
-१.८० करोड
Net income
४३.३० करोड
४८.०० करोड
३६.९० करोड
-५७.६० करोड
Net profit margin
९.६७%
१०.१९%
९.२७%
-१३.९१%
Earnings per share
०.७८
०.९६
०.५३
०.०२
Interest and investment income
-
९.२० करोड
-
-
Interest expense
-२०.५० करोड
-२८.०० करोड
-१९.१० करोड
-१८.६० करोड
Net interest expenses
-२०.५० करोड
-१८.८० करोड
-१९.१० करोड
-१८.६० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१.३२ अरब
१.५४ अरब
१.०० अरब
४०.८० करोड
Gain or loss from assets sale
-
-
-८०.०० लाख
-१.२० करोड
AI content may include mistakes. Learn more
Google एपहरू